From a microfluidic system designed to enhance CAR-T cell production to a digital tool facilitating connections between healthcare professionals and families in medical deserts, encompassing compliance services and an early detection application for neurodegenerative diseases, these entities have recently joined the Eurobiomed community.
Discover Badia Medtech, BloomYou, DeepPulseNeuro, Famille santé, Meranko Pharma, Neuraccure, Progastrin Manufacturing, SWTE / Kontoir, Tebuna Biotechnology, and Therallo.
Badia Medtech
Badia Medtech is developing a microfluidic system designed to separate white blood cells from whole blood. This microfluidic system, which operates without chemicals, agitation, or centrifugation, aims to produce higher-quality CAR-T cells more cost-effectively and rapidly.
BloomYou
BloomYou is developing a digital therapeutic medical device application to support trauma recovery, complementing treatments prescribed by psychiatrists.
DeepPulseNeuro
DeepPulseNeuro is developing a Class III medical device for epilepsy monitoring via endovascular intracranial EEG measurement. The device will be specifically utilized to localize and diagnose epileptic seizures.
Famille santé
Famille santé is developing a tool that connects pediatric healthcare professionals with families. The solution aims to address the issue of medical deserts by providing rapid digital access to medical advice.
Meranko Pharma
Meranko Pharma is a company specializing in supporting pharmaceutical laboratories and medical device manufacturers. It offers services in regulatory affairs, quality assurance, commercial strategy, and market entry into the French market. The company particularly assists foreign stakeholders in complying with local requirements.
Neuraccure
Neuraccure is developing Brain-NET, a digital application for the early diagnosis of neurodegenerative diseases, utilizing tests that analyze brain activity. It is also employed in sports to monitor brain activity recovery following head trauma or repeated microtraumas, thereby preventing the onset of irreversible neurological sequelae.
Progastrin Manufacturing
Progastrin Manufacturing is an oncology-focused company that commercializes an in vitro diagnostic kit for monitoring HPG80 from a single drop of blood. HPG80 is an innovative biomarker for tracking tumor activity. Its objective is to enhance early detection and monitoring of cancers through innovative tools.
SWTE
SWTE, also known as Kontoir, is a startup developing a SaaS solution for pharmacies. The software aims to help pharmacies enhance their commercial efficiency by increasing sales through cross-selling: recommending parapharmacy product(s) as a complement to medication prescribed by a physician.
Tebuna Biotechnology
Tebuna Biotechnology is developing Non-Antibody-Based Binders using generative AI and novel screening technologies. Due to their small size and computational design, they offer various advantages over traditional antibodies, such as penetration of tissue/cell membranes in live-cell studies and the design of targeted epitopes for new functional investigations.
Therallo
Therallo is developing a method for in vitro or ex vivo genetic modification of immune cells and/or pluripotent cells, intended for use in cell therapy, such as autologous and allogeneic cell therapy.
